What’s The Short Term Opportunity In This Pharmaceutical Company: Avenue Therapeutics Inc. (NASDAQ: ATXI )
Avenue Therapeutics Inc. (NASDAQ: ATXI) is a specialty pharmaceutical company that develops and markets pharmaceutical products for the acute care setting. It focuses on developing its product candidate, an intravenous (IV) formulation of tramadol HCI (IV Tramadol), for post-operative acute pain. Avenue is headquartered in New York City and was founded by Fortress Biotech, Inc.